Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
Happy Tuesday everyone! Tonight we are going to get an update on the HSG Clinical Trial for Huntington's disease called First-HD and ARC-HD. Our incredible special guests are:
Samuel Frank, MD – First-HD and ARC-HD PI Claudia Testa, MD, PhD – First-HD and ARC-HD co-PI David Stamler, MD – CMO Auspex Pharmaceuticals Sarah Janicki, MD, MPH – Site Investigator, Columbia for First-HD
We will be discussing the changes to the First-HD protocol with more sites added to help increase participation. We will also be talking with a site investigator, coordinator, and caregiver to get their perspective on how to make clinical trials a more positive experience for everyone.
